Identification of occult metastases of medullary thyroid carcinoma by pentagastrin-stimulated intravenous calcitonin sampling followed by targeted surgery

Clin Endocrinol (Oxf). 2007 Mar;66(3):405-9. doi: 10.1111/j.1365-2265.2007.02747.x.

Abstract

Background: High calcitonin (CT) serum levels suggest metastatic spread in medullary thyroid carcinoma (MTC) after thyroidectomy. In limited disease stages, however, morphological investigations including ultrasound, magnetic resonance imaging (MRI) and 18F-FDG positron emission tomography ([18F]FDG-PET) may often fail to identify exact tumour sites.

Objective: The aim of the present study was to establish an improved strategy to identify small cervical tumours by combining pentagastrin stimulation with bilateral cervical intravenous CT sampling followed by high-resolution ultrasound.

Design and patients: Six MTC patients were examined, of whom five patients already had bilateral neck dissection. Five patients had sporadic MTC, and one patient suffered from MEN2a.

Results: Retrospective analysis of all patients revealed a highly sensitive positive correlation between an early calcitonin peak (20-40 s after pentagastrin injection) and site of cervical tumour affection. Postinterventional ultrasound examination of the affected regions of the neck revealed suspicious presence; in some cases small lymph nodes of less than 1 cm in size were then surgically excised. On histology, small tumours could be identified in four patients. Postsurgical examination revealed a clear decline of basal serum calcitonin levels in four patients (between -41% and -100%). In two patients CT normalized to baseline levels (< 10 pg/ml) and in another two patients CT rendered to near normal (14 and 17 pg/ml).

Conclusion: Pentagastrin stimulation-based intravenous catheter sampling may be beneficial in the diagnostic work-up of MTC after thyroidectomy. Our data show that an early calcitonin peak (20-40 s after administration of pentagastrin) helps to identify tumour-affected regions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biomarkers, Tumor / blood*
  • Calcitonin / blood*
  • Carcinoma, Medullary / secondary*
  • Carcinoma, Medullary / surgery
  • Female
  • Humans
  • Luminescence
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Multiple Endocrine Neoplasia Type 2a / secondary
  • Multiple Endocrine Neoplasia Type 2a / therapy
  • Neoplasm, Residual / diagnosis*
  • Neoplasm, Residual / surgery
  • Pentagastrin*
  • Retrospective Studies
  • Thyroid Neoplasms / secondary*
  • Thyroid Neoplasms / surgery
  • Thyroidectomy

Substances

  • Biomarkers, Tumor
  • Calcitonin
  • Pentagastrin